Waters Retained Earnings (Accumulated Deficit) 2010-2024 | WAT
Waters retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Waters retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $9.789B, a 6.97% increase year-over-year.
- Waters retained earnings (accumulated deficit) for 2024 were $9.789B, a 6.97% increase from 2023.
- Waters retained earnings (accumulated deficit) for 2023 were $9.151B, a 7.55% increase from 2022.
- Waters retained earnings (accumulated deficit) for 2022 were $8.509B, a 9.07% increase from 2021.
| Waters Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $9,789 |
| 2023 | $9,151 |
| 2022 | $8,509 |
| 2021 | $7,801 |
| 2020 | $7,108 |
| 2019 | $6,587 |
| 2018 | $5,995 |
| 2017 | $5,405 |
| 2016 | $5,385 |
| 2015 | $4,864 |
| 2014 | $4,395 |
| 2013 | $3,963 |
| 2012 | $3,513 |
| 2011 | $3,051 |
| 2010 | $2,618 |
| 2009 | $2,237 |
| Waters Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $9,789 |
| 2024-09-30 | $9,557 |
| 2024-06-30 | $9,396 |
| 2024-03-31 | $9,253 |
| 2023-12-31 | $9,151 |
| 2023-09-30 | $8,935 |
| 2023-06-30 | $8,800 |
| 2023-03-31 | $8,650 |
| 2022-12-31 | $8,509 |
| 2022-09-30 | $8,282 |
| 2022-06-30 | $8,126 |
| 2022-03-31 | $7,961 |
| 2021-12-31 | $7,801 |
| 2021-09-30 | $7,585 |
| 2021-06-30 | $7,423 |
| 2021-03-31 | $7,256 |
| 2020-12-31 | $7,108 |
| 2020-09-30 | $6,890 |
| 2020-06-30 | $6,763 |
| 2020-03-31 | $6,640 |
| 2019-12-31 | $6,587 |
| 2019-09-30 | $6,387 |
| 2019-06-30 | $6,249 |
| 2019-03-31 | $6,104 |
| 2018-12-31 | $5,995 |
| 2018-09-30 | $5,810 |
| 2018-06-30 | $5,669 |
| 2018-03-31 | $5,513 |
| 2017-12-31 | $5,405 |
| 2017-09-30 | $5,759 |
| 2017-06-30 | $5,622 |
| 2017-03-31 | $5,491 |
| 2016-12-31 | $5,385 |
| 2016-09-30 | $5,211 |
| 2016-06-30 | $5,086 |
| 2016-03-31 | $4,958 |
| 2015-12-31 | $4,864 |
| 2015-09-30 | $4,713 |
| 2015-06-30 | $4,596 |
| 2015-03-31 | $4,491 |
| 2014-12-31 | $4,395 |
| 2014-09-30 | $4,243 |
| 2014-06-30 | $4,130 |
| 2014-03-31 | $4,033 |
| 2013-12-31 | $3,963 |
| 2013-09-30 | $3,821 |
| 2013-06-30 | $3,723 |
| 2013-03-31 | $3,634 |
| 2012-12-31 | $3,513 |
| 2012-09-30 | $3,337 |
| 2012-06-30 | $3,238 |
| 2012-03-31 | $3,140 |
| 2011-12-31 | $3,051 |
| 2011-09-30 | $2,914 |
| 2011-06-30 | $2,813 |
| 2011-03-31 | $2,713 |
| 2010-12-31 | $2,618 |
| 2010-09-30 | $2,492 |
| 2010-06-30 | $2,397 |
| 2010-03-31 | $2,312 |
| 2009-12-31 | $2,237 |
| 2009-09-30 | $2,133 |
| 2009-06-30 | $2,057 |
| 2009-03-31 | $1,987 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $19.099B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
| Thermo Fisher Scientific (TMO) | United States | $161.378B | 19.56 |
| Alcon (ALC) | Switzerland | $45.645B | 30.34 |
| Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
| IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
| DexCom (DXCM) | United States | $26.887B | 41.56 |
| IQVIA Holdings (IQV) | United States | $25.374B | 14.04 |
| STERIS (STE) | Ireland | $21.834B | 24.97 |
| Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.16 |
| Hologic (HOLX) | United States | $12.916B | 13.94 |
| Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
| Penumbra (PEN) | United States | $10.729B | 96.64 |
| Globus Medical (GMED) | United States | $9.767B | 22.61 |
| Masimo (MASI) | United States | $8.221B | 34.50 |
| Teleflex (TFX) | United States | $6.004B | 9.24 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
| TransMedics (TMDX) | United States | $2.985B | 87.37 |
| PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
| Veracyte (VCYT) | United States | $2.427B | 43.86 |
| Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
| LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
| Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
| Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
| Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Paragon 28 (FNA) | United States | $1.099B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 91.72 |
| OPKO Health (OPK) | United States | $0.954B | 0.00 |
| AxoGen (AXGN) | United States | $0.690B | 0.00 |
| IRadimed (IRMD) | United States | $0.658B | 34.51 |
| Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| RxSight (RXST) | United States | $0.584B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
| OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
| Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
| 908 Devices (MASS) | United States | $0.168B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.152B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |